Takeda

Views & Analysis

Transforming oncology outcomes through data and digital

The healthcare industry is evolving rapidly, with data and digital technologies transforming everyday communications as we know them.

News

Dengue, zika and chikungunya fever mosquito (aedes aegypti) on human skin

Takeda gets first approval for its dengue vaccine

Japan's Takeda has secured its first regulatory approval – in Indonesia – for its dengue fever vaccine TAK-003, which has been tipped as a potential blockbuster product.

News

CSL preps filings for once-monthly antibody for HAE

Australia's CSL has said its one-monthly treatment for hereditary angioedema has shown it is safe and effective in a phase 3 trial, and will be filed for approval in its current financial y

News

After coeliac fail, 9 Meters plots phase 3 in short bowel sy...

Two weeks after reporting disappointing results for its lead coeliac disease therapy, 9 Meters Biopharma will draw some comfort from a mid-stage trial of its candidate for short bowel syndr

News

Takeda bolsters data for dengue jab as regulatory reviews ro...

Takeda has reported positive new, long-term results in its pivotal trial of dengue fever vaccine TAK-003 that builds the case for the shot as regulators review marketing applications.

Market Access